Executive panel recommends nod to SII for segment 2/three trials of Covovax on kids elderly 2-17
Knowledgeable panel of India’s Central Drug Authority on Tuesday beneficial granting permission to Serum Institute of India (SII) for carrying
Read More
Covid vaccine trial on children